Treatment of gastrointestinal (GI) cancers is catching up with other areas of oncology and offering patients better prospects for survival and quality...
Vous n'êtes pas connecté
Patients with treatment-refractory cancers who received eligibility and testing waivers to participate in a large basket/umbrella oncology trial had similar rates of clinical benefit and adverse events as patients who participated in the trial without waivers.
Treatment of gastrointestinal (GI) cancers is catching up with other areas of oncology and offering patients better prospects for survival and quality...
The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details best practices for using radiation therapy...
The 14-month median follow-up data from the pivotal Phase 1/2 LINKER-MM1 trial of linvoseltamab in patients with relapsed/refractory (R/R) multiple...
A Cleveland Clinic study shows that bariatric surgery performed in patients with obesity and moderate to severe obstructive sleep apnea is associated...
Treatment of gastrointestinal (GI) cancers is catching up with other areas of oncology and offering patients better prospects for survival and quality...
THURSDAY, June 27, 2024 -- Acupuncture can help breast cancer patients deal with the hot flashes that often accompany hormone therapy, a new clinical...
Cross-border tumour boards of cancer specialists from different European countries meeting virtually to review the management of individual patients...
An analysis of data from a randomised clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib,...
WHO estimates that there are 39 million HIV patients living in the world with a death rate of around 630,000 per year. A figure that seems high but 20...
Pancreatic cancer patients who underwent chemotherapy both before and after surgery had longer survival rates compared to those who received...